Cited by 118Renin-Angiotensin System StudiesNitric Oxide and Endothelin EffectsEicosanoids and Hypertension Pharmacology

Angiotensin II type 1 receptor-mediated peroxide production in human macrophages

Yanagitani, Yoshihiro, Rakugi, Hiromi, Okamura, Atsunori, Moriguchi, Koichi, Takiuchi, Shin, Ohishi, Mitsuru, Suzuki, Keiichiro, Higaki, Jitsuo +1 more·1999·Hypertension

Abstract

Our previous experiments demonstrated upregulation of the renin-angiotensin system in macrophages, including angiotensin II type 1 (AT1) and type 2 (AT2) receptors, during transformation from monocytes. We investigated the role of angiotensin II in oxidative stress of monocytes/macrophages, which plays a role in the advance of atherosclerosis. THP1, a human monocytic leukemia cell line, was differentiated to macrophages by adding of phorbol 12-myristate 13-acetate for 24 hours. The intracellular production of peroxide was measured by a cytofluorometric assay with 2', 7'-dichlorofluorescein-diacetate with a flow cytometer scan. Peroxide was detected in monocytes and upregulated during the transformation to macrophages by 3.18+/-0.52 times in relative fluorescein of peak value (P<0.01). Angiotensin II (1 micromol/L) induced oxidative stress in macrophages, with the peak at 15 minutes by 451+/-223%, and returned to the control level within 1 hour. EC50 was 5.4x10(-9) mol/L. AT1 antagonist (CV11974, 1 micromol/L) significantly decreased angiotensin II-induced oxidative stress in macrophages, but AT2 antagonist (PD123319, 1 micromol/L) did not. Of interest, AT1 antagonist also decreased basal levels of peroxide production in macrophages in a dose-dependent manner. These results suggest that upregulation of the expression of AT1 receptor in macrophages contributes in part to upregulation of peroxide production. AT1 receptor antagonists may be useful to suppress oxidative stress of macrophages in atherosclerotic lesions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.33.1.335

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 37 · Cited by 118

Research works printed but not linked: 2

  1. MERCATOR-Study-Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous trans- luminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Circu- lation. 1992;86:100 -110.
  2. Dzau VJ. Local expression and pathophysiological role of renin-angio- tensin in the blood vessels and heart. Basic Res Cardiol. 1993;1:1-14.

Authors
Yanagitani, Y., Rakugi, H., Okamura, A., Moriguchi, K., Takiuchi, S., Ohishi, M., Suzuki, K., Higaki, J., & Ogihara, T.
Affiliations
The University of Osaka (JP)
Venue
Hypertension
Published
1999-01
Volume
33
Issue
1
Pages
335-339
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2050991399
Cited by
118
References
37
Citations by year
2024: 3 · 2023: 1 · 2021: 4 · 2020: 3 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 4
FWCI
5.95
Type
journal article
Language
en
Open access
closed
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
angiotensin II type 1 receptor, angiotensin II type 2 receptor, macrophages, oxidative stress, reactive oxygen species, peroxide formation, renin-angiotensin system, monocyte-to-macrophage differentiation, atherosclerosis, angiotensin II, AT1 receptor antagonists, PD123319, THP-1 cells
MeSH terms
Angiotensin II, Benzimidazoles, Biphenyl Compounds, Cell Differentiation, Humans, Imidazoles, Kinetics, Leukemia, Monocytic, Acute, Macrophages, Peroxides, Pyridines, Receptors, Angiotensin, Tetradecanoylphorbol Acetate, Tetrazoles, Tumor Cells, Cultured, Oxidative Stress, Receptor, Angiotensin, Type 2, Receptor, Angiotensin, Type 1, Angiotensin Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review